Katherine Lord, MD

female silhouette icon
Katherine Lord, MD is a pediatric endocrinologist and Medical Director of the Inpatient Endocrinology Service at Children's Hospital of Philadelphia

Areas of Expertise: Congenital Hyperinsulinism, Diabetes, Thyroid disorders
Locations: Main Hospital

Appointments and Referrals: 1-800-TRY-CHOP (1-800-879-2467)

Education and Training

Medical School

MD - Northwestern University Feinberg School of Medicine, Chicago, IL


Pediatrics, Yale New Haven Children's Hospital, New Haven CT


Pediatric Endocrinology, The Children's Hospital of Philadelphia, Philadelphia, PA

Board Certification

Pediatric Endocrinology – American Board of Pediatrics
Pediatrics – American Board of Pediatrics

Titles and Academic Titles

Attending Physician

Associate Professor of Pediatrics, Perelman School of Medicine at the University of Pennsylvania

Departments and Services




Adzick NS, De Leon DD, States LJ, Lord K, Bhatti TR, Becker SA, Stanley CA. Surgical treatment of congenital hyperinsulinism: Results from 500 pancreatectomies in neonates and children. J Pediatr Surg. 2019 Jan;54(1):27-32. doi: 10.1016/j.jpedsurg.2018.10.030. Epub 2018 Oct 5.


Lord K, Radcliffe J, Gallagher P, Adzick NS, Stanley CA, De León DD: High Risk of Diabetes and Neurobehavioral Deficits in Individuals with Surgically Treated Hyperinsulinism  J Clin Endocrinol Metab 100(11): 4133-4139, November 2015.


Lord K, Dzata E, Snider KE, Gallagher PR, De León DD. Clinical presentation and management of children with diffuse and focal hyperinsulinism: a review of 223 cases. J Clin Endocrinol Metab. 2013 Sep 20. [Epub ahead of print]

Lord K, De León DD. Monogenic hyperinsulinemic hypoglycemia: current insights into the pathogenesis and management. Int J Pediatr Endocrinol. 2013 Feb 6;2013(1):3.

Stanescu DE, Lord K, Lipman TH. The epidemiology of type 1 diabetes in children. Endocrinol Metab Clin North Am. 2012 Dec;41(4):679-94.




Lord K, De Leon DD: Hyperinsulinism. The 5-Minute Pediatric Consult, 7th Edition 2015.


Lord K and Rossi W.: Acquired Hypothyroidism. Decision Support in Medicine 2014.

Posters and Presentations


Lord K, Stewart N, Langdon D, De León DD. Lanreotide is a Safe and Effective Treatment for Congenital Hyperinsulinism. 10th International Joint Meeting of Pediatric Endocrinology, Washington DC September 2017.


Vajravelu ME, Lord K, Givler S, De Leon DD: Protein-induced Hypoglycemia in KATP Hyperinsulinism is Mediated by the GLP-1 Receptor. Eastern Society of Pediatric Research, Philadelphia PA March  2016